Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
W. Bradford Smith currently holds 30,000 shares of Homology Medicines, Inc. (FIXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, W. Bradford Smith has been a net seller of FIXX stock. They have purchased $0 and sold $2.9M worth of shares.
W. Bradford Smith's most recent insider trade was on May 14, 2026, when they sold 640 shares at $0.00 per share.
W. Bradford Smith serves as Executive at Homology Medicines, Inc. (FIXX). They have executed 46 insider transactions totaling $2.9M over their tenure at the company.
W. Bradford Smith holds the position of Executive at Homology Medicines, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
W. Bradford Smith has shown a selling trading pattern, with $0 in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by W. Bradford Smith was on Feb 14, 2006, when they sold $916.0K worth of NURO shares. This transaction involved 26,000 shares at $35.23 per share.
W. Bradford Smith currently owns 30,000 shares of Homology Medicines, Inc. (FIXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of W. Bradford Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. W. Bradford Smith has 46 Form 4 filings on record as an insider at Homology Medicines, Inc..
Set alerts for W. Bradford Smith and 40,000+ other insiders.